ArticleMolecular cancer therapeutics2020

Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.

Vindhya Udhane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.